Identification and genetic analysis of new mutations in EYA1 gene of BOS syndrome.
10.3760/cma.j.cn115330-20210126-00040
- VernacularTitle:鳃耳综合征
EYA1基因新突变的鉴定及遗传学分析
- Author:
Jing MA
1
;
Rui HUANG
1
;
Xiu Li MA
1
;
Xia LI
1
;
Tie Song ZHANG
1
;
Biao RUAN
2
Author Information
1. Department of Otorhinolaryngology Head and Neck Surgery, Kunming Children's Hospital, Kunming Key Laboratory for Prevention and Control of Congenital Birth Defects of Children, Yunnan Key Laboratory of Children's Major Disease Research, Kunming 650228, China.
2. Department of Otorhinolaryngology, the First Hospital of Kunming Medical University, Kunming 650032, China.
- Publication Type:Journal Article
- MeSH:
Branchio-Oto-Renal Syndrome/genetics*;
DNA Mutational Analysis;
Female;
Genetic Testing;
Humans;
Intracellular Signaling Peptides and Proteins/genetics*;
Mutation;
Nuclear Proteins;
Pedigree;
Protein Tyrosine Phosphatases/genetics*
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2021;56(9):966-971
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To analyze the clinical manifestations of a patient with branchiootic syndrome(BOS) and her families and to carry out genetic testing in order to specify the biological pathogenesis. Methods: Clinical data of the patient and her families were collected. Genomic DNA in the peripheral blood of the proband and her family members was extracted. All exons of 406 deafness-related susceptible genes as well as their flanking regions were sequenced by high-throughput sequencing, and the mutation sites of the proband and her parents were validated by Sanger sequencing. Results: There were nine members in three generations, of whom four presented with hearing loss, preauricular fistula and branchial fistula which met the diagnostic criteria of BOS. Proband and her mother presented with auricle malformation and inner ear malformation. And no one had abnormalities in the kidneys of all the patients. Pedigree analysis revealed that the mode of inheritance in the family was consistent with the autosomal dominant pattern. Mutational analysis showed that all the affected patients detected a heterozygous frameshift variation c.1255delT in the EYA1 gene, which had not been reported. Genotype and phenotype were co-isolated in this family. Such a frameshift variation produced a premature termination codon, thereby causing premature termination of translation (p.C419VFS*12). ACMG identified that the mutation was pathogenic. This mutation was novel and not detected in controls. A heterozygous missense variation mutation c.403G>A(p.G135S) in EYA1 gene was also detected in three members of this family. ACMG identified that the mutation clinical significance was uncertain. However, two of whom were normal, which seemed the disease was not caused by this mutation in this family. Conclusions: A novel frameshift mutation in EYA1(c.1255delT) is the main molecular etiology of BOS in the Chinese family. This study expands the mutational spectrum of EYA1 gene. The clinical manifestations are heterogeneous among patients in this family. The diagnosis of BOS should combine gene tests with clinical phenotypes analysis.
